Clinical laboratories certified under Clinical Laboratory Improvement Amendments can immediately begin using this kit to detect SARS-CoV-2, the virus that causes COVID-19.
PerkinElmer's RT-PCR test is marketed as an in vitro diagnostic device by meeting the requirements of the European In Vitro Diagnostic Directive and is available in over 30 countries worldwide.
PerkinElmer offers solutions to serve the diagnostics, life sciences, food and applied markets.
The company reported revenue of approximately USD 2.9bn in 2019, serves customers in 190 countries, and is a component of the S and P 500 index.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project